Alzheimer's Disease costs U.S. society over $100 billion annually, making it the 3rd most costly disease after heart disease and cancer.
Alzheimer's Disease affects 1 out of every 4 people over the age of 75, and 1 out of 3 people over 80.
Presently, there are 35 million cases of Alzheimer's Disease worldwide. This number is expected to increase to 115.4 million by 2050.
A two-day global conference for research scientists to engage in discussion and cross fertilization of ideas focusing on Alzheimer’s drug discovery research.
A one-day meeting focusing on European biotechnology companies conducting early-stage high risk research for Alzheimer’s disease that complement approaches in advanced clinical trials. This is a satellite meeting to be held in conjunction with the 3rd Clinical Trials on Alzheimer’s Disease conference.
Inaugural Fall Luncheon - September 22, 2010 at The Pierre Hotel, New York City.
See News and Events for more information.